甲状旁腺全切联合前臂自体移植术在三发性甲状旁腺功能亢进症中的应用价值分析

doi:10.3969/j.issn.1001-8131.2024.04.004

Abstract
Figure/Table
References
Related Citation (1)

Download: PDF (496 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective Exploring the value of total parathyroidectomy combined with forearm autotransplantation in the treatment of triple hyperparathyroidism.Method 144 patients with triple essential hyperparathyroidism were randomLy divided into a control group and a study group,with 72 cases in each group.The control group underwent total parathyroidectomy for treatment,while the study group underwent forearm autologous transplantation on the basis of the control group.The biochemical indicators,quality of life,HGB,ALB levels,symptom scores,and clinical efficacy of the two groups of patients were compared.Result After treatment,the patients in the study had lower levels of iPTH,Ca,P,Mg,bone pain VAS,pruritus VAS and sleep SRSS than the control group（P<0.05）.After treatment,the patients in the study had higher levels of ALP,quality of life and treatment efficacy than the control group（P<0.05）.Conclusion In patients with triple hyperparathyroidism,the combination of total parathyroidectomy and forearm autograft showed good clinical efficacy,which not only significantly improved the patients' biochemical indicators,but also their quality of life.

Key words： Tertiary hyperparathyroidism Total parathyroidectomy Forearm autotransplantation Biochemical indicators

Received: 19 March 2024

PACS:

R581

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Luo Xiaomin
	Shi Hongxia
	Guo Fang
	Song Yinping
	Zhang Junjie

Cite this article:

Luo Xiaomin,Shi Hongxia,Guo Fang, et al. Analysis of the Application Value of Total Parathyroidectomy Combined with Forearm Autotransplantation in Triple Essential Hyperparathyroidism[J]. journal1, 2024, 44(4): 12-15.

URL:

http://www.hrbyybjb.org.cn/EN/10.3969/j.issn.1001-8131.2024.04.004 OR http://www.hrbyybjb.org.cn/EN/Y2024/V44/I4/12

[1] 吕勇,王秋园,程靖宁,等.甲状旁腺次全切除术与甲状旁腺全切除术联合前臂自体移植术治疗肾移植手术后三发性甲状旁腺功能亢进症的疗效比较[J].中国血液净化,2023,22(5):355-358.
[2] 宫喜翔,卢永新,杨丽萍,等.三发性甲状旁腺功能亢进症合并甲状腺癌及颈部淋巴结结节病1例[J].临床耳鼻咽喉头颈外科杂志,2021,35(1):77-79.
[3] Parpounas C,Lyssiotis T,Constantinides V.Triple water clear cell parathyroid adenomas:a rare cause of primary hyperparathyroidism.BMJ Case Rep.2022 Apr 12;15(4):e246873.
[4] Cinti F,Cavaliere L,Degna MT,,et al.Triple Pelvic Osteotomy Fixed with Lag Screw for the Treatment of Pelvic Canal Stenosis in Five Cats.Vet Comp Orthop Traumatol..Triple Pelvic Osteotomy Fixed with Lag Screw for the Treatment of Pelvic Canal Stenosis in Five Cats.Vet Comp Orthop Traumatol.2020 Sep;33(5):363-369.
[5] 梅威琪,江茂情,马丽娟,等.多模态影像学术前定位诊断原发性及继发于慢性肾病的甲状旁腺功能亢进症[J].中国医学影像技术,2023,39(10):1492-1496.
[6] 黄泽宇,苏磊,桑剑锋,等.正常血钙型原发性甲状旁腺功能亢进症的临床特征及影响因素研究[J].中国全科医学,2023,26(11):1369-1374.
[7] Koumakis E,Gauthé M,Martinino A,,et al.FCH-PET/CT in Primary Hyperparathyroidism With Discordant/Negative MIBI Scintigraphy.FCH-PET/CT in Primary Hyperparathyroidism With Discordant/Negative MIBI Scintigraphy and Ultrasonography.J Clin Endocrinol Metab.2023 Jul 14;108(8):1958-1967.
[8] Giudici F,Fortuna L,Russo E,,et al.Surgery for Sporadic Primary Hyperparathyroidism:Evolution over the Last Twenty Years in a Monocentric Setting.Cancers.Surgery for Sporadic Primary Hyperparathyroidism:Evolution over the Last Twenty Years in a Monocentric Setting.Cancers(Basel).2023 Apr 30;15(9):2581.
[9] 魏林枫,李润生,赵晖,等.甲状旁腺全切除术在慢性肾功能衰竭继发性甲状旁腺功能亢进症治疗中的应用[J].中华普通外科杂志,2023,38(10):749-753.
[10] 毕婷,冯晓东,张巍,等.继发性甲状旁腺功能亢进症患者行甲状旁腺全切术后高钾血症的预测分析[J].医学研究与战创伤救治,2023,36(5):479-483.
[11] Lu DN,Zhang WC,Zheng CM,,et al.Case report:Successful treatment of a rare case of combined parathyroid adenoma.Case report:Successful treatment of a rare case of combined parathyroid adenoma,cervical bronchogenic cyst,and tracheal diverticulum with gasless endoscopic resection of neck masses via an axillary approach:A case report and literature review.Front Oncol.2022 Sep 23;12:947422.
[12] 南娜佳,朱琼琼.骨化三醇不同给药方式联合西那卡塞治疗维持血透继发甲状旁腺功能亢进症的临床疗效[J].中国处方药,2023,21(5):53-57.
[13] 耿兴花,易为,董庆华,等.西那卡塞对维持性血液透析伴继发性甲状旁腺功能亢进症患者成纤维细胞生长因子23 水平和心血管事件的影响[J].中国医药,2023,18(2):242-246.
[14] E Y,Xue H,Zhang CY,,et al.The clinicopathological.The clinicopathological and prognostic significances of CDC73 expression in breast cancer:A pathological and bioinformatics analysis.Histol Histopathol,2023 Apr;38(4):453-465.
[15] Bilezikian JP,Khan AA,Silverberg SJ,,et al.International Workshop on Primary Hyperparathyroidism.Evaluation.International Workshop on Primary Hyperparathyroidism.Evaluation and Management of Primary Hyperparathyroidism:Summary Statement and Guidelines from the Fifth International Workshop.J Bone Miner Res.2022 Nov;37(11):2293-2314.
[16] 卢坤,郝晓飞,董洁,等.99Tcm-MIBI甲状旁腺显像与血清PTH在原发性甲状旁腺功能亢进症中的诊断价值[J].临床和实验医学杂志,2023,22(15):1664-1667.
[17] 王忠祥,庄雪明,张烨,等.骨化三醇常规疗法与冲击疗法对维持性血液透析继发性甲状旁腺功能亢进症患者外周血PTH、Notch1水平和血管钙化的影响[J].中国医院用药评价与分析,2023,23(10):1210-1213.
[18] Guimarães LM,Valeriano AT,Rebelo Pontes HA,,et al.Manifestations of hyperparathyroidism in the jaws:Concepts.Manifestations of hyperparathyroidism in the jaws:Concepts,mechanisms,and clinical aspects.Oral Surg Oral Med Oral Pathol Oral Radiol.2022 May;133(5):547-555.
[19] Medina JE,Randolph GW,Angelos P,,et al.Primary hyperparathyroidism:Disease of diverse genetic.Primary hyperparathyroidism:Disease of diverse genetic,symptomatic,and biochemical phenotypes.Head Neck.2021 Dec;43(12):3996-4009.
[20] 崔恒锋,宋留龙,林凤力,等.继发性甲状旁腺功能亢进症行甲状旁腺切除术术后并发症的预防和治疗[J].中国现代普通外科进展,2023,26(2):151-153.